Ramesh Baliga
26Patents
8h-index
21Co-inventors
71Inventor score
Filing activity: Dec 6, 2005 → Apr 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9764039B2 | Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 18 | Active |
| US9951134B2 | Modified J-chain | Chemistry; Metallurgy | 16 | Active |
| US9938347B2 | Tumor necrosis factor (TNF) superfamily receptor IgM antibodies and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US10400038B2 | Modified J-chain | Chemistry; Metallurgy | 14 | Active |
| US10604559B2 | Multi-valent hepatitis B virus antigen binding molecules and uses thereof | Physics | 13 | Active |
| US10618978B2 | Binding molecules with modified J-chain | Chemistry; Metallurgy | 13 | Active |
| US10689449B2 | Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US10787520B2 | Multimeric bispecific binding molecules specific for CD20 and CD3 | Chemistry; Metallurgy | 8 | Active |
| US10975147B2 | Modified J-chain | Chemistry; Metallurgy | 7 | Active |
| US7416856B2 | High sensitivity assay for detection of nucleoside diphosphate production | Physics | 7 | Active |
| US10954302B2 | Anti-PD-L1 antibodies | Chemistry; Metallurgy | 7 | Active |
| US9738724B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 6 | Active |
| US10899835B2 | IgM Fc and J-chain mutations that affect IgM serum half-life | Chemistry; Metallurgy | 5 | Active |
| US10669347B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 4 | Active |
| US7824880B2 | High sensitivity assay for detection of nucleoside diphosphate production | Physics | 4 | Active |
| US11401337B2 | Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function | Chemistry; Metallurgy | 4 | Active |
| US9732161B2 | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use | Chemistry; Metallurgy | 3 | Active |
| US11535664B2 | Multi-valent hepatitis B virus antigen binding molecules and uses thereof | Physics | 1 | Active |
| US10501558B2 | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use | Chemistry; Metallurgy | 1 | Active |
| US11542342B2 | Binding molecules with modified J-chain | Chemistry; Metallurgy | 1 | Active |
| US11578131B2 | Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules | Chemistry; Metallurgy | 0 | Active |
| US11344626B2 | Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 0 | Active |
| US12252552B2 | Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use | Chemistry; Metallurgy | 0 | Active |
| US11555075B2 | Modified J-chain | Chemistry; Metallurgy | 0 | Active |
| US11958909B2 | Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.